United States News All stories

Tencent Music Entertainment Group (NYSE:TME) has completed its acquisition of Ximalaya, consolidating its position within China's online music and long-form audio sectors.

GSK (NYSE:GSK) announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved a label expansion for Arexvy, its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine.

China Automotive Systems (NASDAQ:CAAS) has commenced the volume shipment of its electric power steering (EPS) systems to the European division of a major global automotive manufacturer.

Brand Engagement Network (NASDAQ:BNAI) delivered its strongest quarterly financial performance since its initial public offering during the first quarter of 2026.

Guangzhou-based electric vehicle maker Xpeng (NYSE:XPEV) has commenced mass production of its inaugural robotaxi model at its corporate headquarters, accelerating its strategic push into autonomous mobility.

Baidu (NASDAQ:BIDU) reported a significant expansion in its core artificial intelligence business for the first quarter of 2026, helping cushion the impact of a marginal sequential contraction in its top-line revenue.

iQIYI (NASDAQ:IQ) swung to an operating and net loss in the first quarter of 2026, driven by a double-digit decline in its top-line performance.

Sohu.com (NASDAQ:SOHU) reported initial top-line revenue expansion for the first quarter of 2026, beating conservative market forecasts as robust multiplayer gaming activity compensated for ongoing structural shifts across the broader Chinese digital advertising landscape.

HIVE Digital Technologies (NASDAQ:HIVE) announced a massive expansion of its high-performance computing footprint, revealing a multi-billion-dollar plan to develop a premier industrial-scale artificial intelligence data center in Ontario.

SunCar Technology Group (NASDAQ:SDA) released its preliminary, unaudited financial estimates for the first quarter ended March 31, 2026, signaling a major financial turnaround.

CervoMed (NASDAQ:CRVO) reported its financial results for the first quarter of 2026, alongside corporate and clinical milestones for its lead oral small-molecule drug candidate, neflamapimod.

Niu Technologies (NASDAQ:NIU), a leading provider of smart electric two-wheel vehicles, announced its unaudited financial results for the first quarter ended March 31, 2026.

WeRide (NASDAQ:WRD) reported that its mass-production driving solution achieved a record-breaking performance at the Hefei round of the Second China Urban Intelligent Driving Competition, marking a significant milestone for the company’s Level 2++ autonomous systems.

V2X (NYSE:VVX) has been awarded a contract by the U.S. Navy’s Naval Air Systems Command (NAVAIR) to support the Large Aircraft Infrared Countermeasures (LAIRCM) program.

Bitcoin Depot (NASDAQ:BTM) has filed for voluntary Chapter 11 bankruptcy protection to facilitate an orderly wind-down of its business and a sale of its corporate assets.

Philips (NYSE:PHG), in partnership with healthcare technology firms Cuviva and Vingmed, has been selected by Region Stockholm to implement a large-scale hospital-at-home program.

Edible Garden (NASDAQ:EDBL) reported strong top-line revenue growth for the first quarter of 2026, driven by retail expansion and broader consumer adoption of its product portfolio, even as heavy capital deployment for its beverage infrastructure weighed on near-term profitability.

Arrive AI (NASDAQ:ARAI), a company developing AI-powered autonomous vehicle and robotics solutions, announced its first-quarter 2026 financial results and provided an operational update.

RenX Enterprises (NASDAQ:RENX) reported strong sequential revenue expansion for the first quarter of 2026, driven by higher utilization across its contracted hauling agreements and accelerating bulk material sales, even as advanced technology integration costs left consolidated bottom-line metrics in a deficit.

Creative Realities (NASDAQ:CREX) reported a significant increase in top-line revenue for the first quarter of fiscal 2026, driven primarily by the financial integration of its Cineplex Digital Media acquisition, even as margin compression and one-time structural charges pulled bottom-line metrics into a deficit.

Palvella Therapeutics (NASDAQ:PVLA) reported positive clinical data from its Phase 2 TOIVA trial evaluating its proprietary topical formulation of rapamycin, detailing significant therapeutic benefits for patients suffering from rare vascular skin disorders.

RBC Bearings Incorporated (NYSE:RBC) reported strong financial results for the fourth quarter of fiscal 2026, beating Wall Street expectations as accelerating production rates across commercial aviation and defense programs catalyzed top-line growth.

MiNK Therapeutics (NASDAQ:INKT) reported its first-quarter 2026 financial results and operational milestones, highlighting clinical advancement within its invariant natural killer T (iNKT) cell platform alongside successful balance sheet deleveraging.

Digi Power X (NASDAQ:DGXX) reported a wider net loss for the first quarter of 2026, reflecting the financial impacts of its ongoing structural transition away from legacy business operations and toward high-density artificial intelligence infrastructure.